KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $741000.0.

  • Twist Bioscience's Other Non-Current Liabilities rose 8206.39% to $741000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $741000.0, marking a year-over-year increase of 8206.39%. This contributed to the annual value of $747000.0 for FY2025, which is 8353.81% up from last year.
  • As of Q4 2025, Twist Bioscience's Other Non-Current Liabilities stood at $741000.0, which was up 8206.39% from $747000.0 recorded in Q3 2025.
  • Twist Bioscience's 5-year Other Non-Current Liabilities high stood at $28.4 million for Q4 2021, and its period low was $60000.0 during Q3 2022.
  • Its 5-year average for Other Non-Current Liabilities is $3.1 million, with a median of $475000.0 in 2023.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 1340857.14% in 2021, then plummeted by 9978.85% in 2022.
  • Quarter analysis of 5 years shows Twist Bioscience's Other Non-Current Liabilities stood at $28.4 million in 2021, then plummeted by 99.79% to $60000.0 in 2022, then soared by 691.67% to $475000.0 in 2023, then decreased by 14.32% to $407000.0 in 2024, then surged by 82.06% to $741000.0 in 2025.
  • Its Other Non-Current Liabilities was $741000.0 in Q4 2025, compared to $747000.0 in Q3 2025 and $688000.0 in Q2 2025.